Press "Enter" to skip to content

New patent for Boehringer Ingelheim drug JENTADUETO

0
Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for JENTADUETO
Annual Drug Patent Expirations for JENTADUETO

Jentadueto is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from one supplier. There are ten patents protecting this drug and two Paragraph IV challenges.

JENTADUETO drug price trends.

Drug patent litigation for JENTADUETO.

The generic ingredient in JENTADUETO is linagliptin; metformin hydrochloride. One supplier is listed for this compound. Additional details are available on the linagliptin; metformin hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at

    Leave a Reply

    DrugPatentWatch - Make Better Decisions